Christopher A Salvatore

Title: Christopher A. Salvatore: Innovator in Biopharmaceuticals

Introduction

Christopher A. Salvatore is a prominent inventor based in North Wales, PA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative receptor technologies. With a total of 5 patents to his name, Salvatore's work has advanced the understanding and application of humanized receptors in medical research.

Latest Patents

Salvatore's latest patents include groundbreaking inventions such as isolated DNA molecules encoding humanized calcitonin gene-related peptide receptors. This invention details isolated nucleic acid molecules that encode a humanized version of the calcitonin gene-related peptide (CGRP) receptor. The humanized CGRP receptors achieve pharmacological profiles similar to the wild type human receptor through specific modifications to the mammalian RAMP1 nucleotide sequence. Additionally, he has developed recombinant human adenosine receptors A1, A2a, A2b, and A3, which are prepared using cDNA cloning and polymerase chain reaction techniques. These receptors can be utilized in assays to identify and evaluate entities that bind to or enhance binding to adenosine receptors.

Career Highlights

Christopher A. Salvatore is currently associated with Merck & Co., Inc., where he continues to innovate and contribute to the field of biopharmaceuticals. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Salvatore has collaborated with notable colleagues, including Marlene A. Jacobson and Robert G. Johnson. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Christopher A. Salvatore is a distinguished inventor whose contributions to biopharmaceuticals have had a lasting impact on the field. His innovative patents and collaborations reflect his commitment to advancing medical science.